Top Markets
#1 ADO Protocol ADO Protocol +193.34%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +44.27%
#4 GAIB AID GAIB AID +24.67%
#5 SkyAI SkyAI +14.39%
#6 Verus Coin Verus Coin +13.64%
#7 o1.exchange o1.exchange +12.48%
#8 Tutorial Tutorial +12.27%
#9 Casper Network Casper Network +12.23%
#10 Pons Pons +12.22%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Kedudukan dalam Saham #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Harga Saham
$0.5099
Disegerakkan terakhir: 2024-10-15
Modal Pasaran
$7.60M
Perubahan (1 hari)
2.02%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Anew Medical, Inc. (WENA)

Kategori

Healthcare
Pendapatan untuk Anew Medical, Inc. (WENA)
Pendapatan pada Jun 2024 TTM: $114.12K
Menurut laporan kewangan terkini Anew Medical, Inc., pendapatan semasa syarikat ialah $114.12K. Pada tahun 2022, syarikat memperoleh pendapatan sebanyak $1.56M, peningkatan berbanding pendapatan pada tahun 2021 yang berjumlah $-1.11M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Anew Medical, Inc. dari 2021 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE